project id: TCGA-GBM; case submitter id: TCGA-74-6581; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; spectrophotometer method: UV Spec; age at index: 77; days to birth: -28263; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1933; age at diagnosis: 28263; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 250.0; icd 10 code: C71.9; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: not reported; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Brain, NOS; synchronous malignancy: Not Reported; tissue or organ of origin: Brain, NOS; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; intermediate dimension: 0.6; longest dimension: 1.2; preservation method: Unknown; shortest dimension: 0.4; sample id: 7d2365b9-746b-46be-9a1e-9a68c268cd72; sample submitter id: TCGA-74-6581-01A; portion id: 724d7be5-c116-46c4-9017-8a2ef374cefb; portion submitter id: TCGA-74-6581-01A-11; slide id: 7569220a-f5a2-4d0f-8113-9532e0183ecb; slide submitter id: TCGA-74-6581-01A-01-TS1; percent necrosis: 15.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 85.0; percent tumor nuclei: 85.0; section location: TOP;